Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (4 ops.)
Latest filing published 05 Jun 2026 for BioAtla, Inc., €93. Read the official filing
Filing timeline
BuySaleJay M. Phd Short
Insider track record
Disclosed buys
4
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+172.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jay M. Phd Short: trading record in brief
This profile gathers the share dealings of Jay M. Phd Short in BioAtla, Inc., where the filings describe the role as chief executive. Between 14 June 2021 and 31 May 2026, the trades on record add up to 43 filings.
Market trades split into 4 purchases (€468k) and 4 sales (€1.5M). Taken together, the sales exceed the purchases by €1.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 32 share grants and 1 option exercise.
The median purchase comes to €95k. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 5 June 2026 with a share grant (€876) in BioAtla, Inc. The clock since the last published purchase (20 December 2023) now reads 1,033 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jay M. Phd Short
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
639 shares@ US$0.1680.0% of flowCommon StockSEC:0001193125-26-259702:0
259 shares@ US$3.930.016% mcap0.0% of flowCommon StockSEC:0001193125-26-259702:1
430,000 shares0Common StockSEC:0001193125-26-104134:0
7,728 shares@ US$0.2470.1% of flowCommon StockSEC:0001193125-26-085971:0
6,347 shares@ US$0.9040.2% of flowCommon StockSEC:0001193125-25-304171:0
6,347 shares@ US$0.45550.1% of flowCommon StockSEC:0000950170-25-112618:0
6,347 shares@ US$0.4090.1% of flowCommon StockSEC:0000950170-25-080994:0
431,000 shares0Common StockSEC:0000950170-25-038746:0
30,911 shares@ US$0.460.3% of flowCommon StockSEC:0000950170-25-025969:0
417,000 shares0Common StockSEC:0001209191-24-003507:0
50,000 shares@ US$2.13822.3% of flowCommon StockSEC:0001209191-23-059387:0
Canonical exit: 19 Mar 2024 (T+90)
2,888 shares@ US$1.470.1% of flowCommon StockSEC:0001209191-23-054075:0
2,888 shares@ US$1.700.1% of flowCommon StockSEC:0001209191-23-051187:0
2,888 shares@ US$2.510.2% of flowCommon StockSEC:0001209191-23-048031:0
2,888 shares@ US$2.990.2% of flowCommon StockSEC:0001209191-23-044052:0
2,888 shares@ US$3.000.2% of flowCommon StockSEC:0001209191-23-040669:0
2,888 shares@ US$3.150.2% of flowCommon StockSEC:0001209191-23-033473:0
2,888 shares@ US$3.370.2% of flowCommon StockSEC:0001209191-23-026662:0
2,888 shares@ US$2.680.2% of flowCommon StockSEC:0001209191-23-022431:0
40,800 shares@ US$2.47212.2% of flowCommon StockSEC:0001209191-23-021720:0
Canonical exit: 27 Jun 2023 (T+90)
2,888 shares@ US$2.890.2% of flowCommon StockSEC:0001209191-23-014295:0
3,517 shares@ US$3.790.3% of flowCommon StockSEC:0001209191-23-006438:0
4,667 shares@ US$8.250.9% of flowCommon StockSEC:0001209191-23-000323:0
4,667 shares@ US$11.011.2% of flowCommon StockSEC:0001209191-22-059271:0
3,454 shares@ US$6.890.6% of flowCommon StockSEC:0001209191-22-055169:0
25 of 43 declarations
